Efficacy and safety of fenofibrate add-on therapy for patients with primary biliary cholangitis and a suboptimal response to UDCA

Efficacy and safety of fenofibrate add-on therapy for patients with primary biliary cholangitis and a suboptimal response to UDCA

ABSTRACT Background: primary biliary cholangitis (PBC) patients with a suboptimal response to ursodeoxycholic acid (UDCA) have a significantly worse survival rate. Fenofibrate has been shown to improve the short-term biochemical response in this group of patients. However, there is limited data av...

Full description

Bibliographic Details
Main Authors: Weijia Duan, Xiaojuan Ou, Xiaoming Wang, Yu Wang, Xinyan Zhao, Qianyi Wang, Xiaoning Wu, Wei Zhang, Hong Ma, Hong You, Jidong Jia
Format: Article
Language:English
Published: Aran Ediciones 2018-09-01
Series:Revista Espanola de Enfermedades Digestivas
Subjects:
Primary biliary cholangitis
Fenofibrate
Ursodeoxycholic acid
Online Access:http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-01082018000900005&tlng=en

Internet

http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-01082018000900005&tlng=en

Similar Items